Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?

As you can see below, Shanghai Haohai Biological Technology had CN¥66.1m of debt at September 2021, down from CN¥81.4m a year prior. But it also has CN¥2.91b in cash to offset that, meaning it has …
( read original story …)